17 beta-estradiol regulation of human endothelial cell basal nitric oxide release, independent of cytosolic Ca2+ mobilization.

Estradiol retards the development of atherosclerosis. Animal models have suggested that NO may be a critical effector molecule in this cardiovascular protection. In this study, female human umbilical vein endothelial cells (HUVECs) were propagated in phenol red-free gonadal hormone-free medium and pretreated with 17 beta-estradiol (E2). Reduced NO2- and NO3- (NOx) concentration, determined by chemiluminescence, demonstrated a rapid increase in basal HUVEC NO release in response to physiological concentrations of E2. The estrogen receptor (ER) antagonist ICI 164,384 inhibited the augmented NO release, demonstrating an ER-mediated component of this response. Because endothelial NO synthase (eNOS) activity is largely regulated by cytosolic Ca2+, relative [Ca2+]i in response to E2 was determined in a fluorometric assay. E2 did not promote HUVEC Ca2+ fluxes. Furthermore, eNOS activity in E2-pretreated endothelial whole-cell lysates was not dependent on additional Ca2+. Despite involving the ER, this is a nongenomic effect E2, as demonstrated by maintained responses in transcriptionally inhibited cells and by the rapidly (10 minutes) of cGMP formation in an NO bioassay. We demonstrate, for the first time, that independent of cytosolic Ca2+ mobilization, there is augmentation of eNOS activity with a resultant increase in HUVEC basal NO release in response to short-term estradiol exposure. Implications for the cardiovascular protective role of estrogen are discussed.

[1]  K. Korach,et al.  Vascular estrogen receptors and endothelium-derived nitric oxide production in the mouse aorta. Gender difference and effect of estrogen receptor gene disruption. , 1997, The Journal of clinical investigation.

[2]  L. Ignarro,et al.  Evidence for the presence of an unusual nitric oxide- and citrulline-producing enzyme in rat kidney. , 1997, Biochemical and biophysical research communications.

[3]  R. Pardi,et al.  Effects of 17beta-estradiol on cytokine-induced endothelial cell adhesion molecule expression. , 1996, The Journal of clinical investigation.

[4]  G. Garcı́a-Cardeña,et al.  Targeting of nitric oxide synthase to endothelial cell caveolae via palmitoylation: implications for nitric oxide signaling. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[5]  R. Busse,et al.  Intracellular pH and tyrosine phosphorylation but not calcium determine shear stress-induced nitric oxide production in native endothelial cells. , 1996, Circulation research.

[6]  A. Nègre-Salvayre,et al.  Ethinylestradiol does not enhance the expression of nitric oxide synthase in bovine endothelial cells but increases the release of bioactive nitric oxide by inhibiting superoxide anion production. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[7]  T. Peterson,et al.  Fluid shear stress stimulates mitogen-activated protein kinase in endothelial cells. , 1995, Circulation research.

[8]  J. Pollock,et al.  The Golgi Association of Endothelial Nitric Oxide Synthase Is Necessary for the Efficient Synthesis of Nitric Oxide(*) , 1995, The Journal of Biological Chemistry.

[9]  Stamatis Adamopoulos,et al.  17β-Estradiol Attenuates Acetylcholine-Induced Coronary Arterial Constriction in Women but Not Men With Coronary Heart Disease , 1995 .

[10]  T. Saruta,et al.  Up‐regulation of nitric oxide synthase by estradiol in human aorticendothelial cells , 1995, FEBS letters.

[11]  R. Pardi,et al.  Lymphocyte adhesion-dependent calcium signaling in human endothelial cells , 1995, The Journal of cell biology.

[12]  D. Harrison,et al.  Regulation of endothelial constitutive nitric oxide synthase by protein kinase C. , 1995, Hypertension.

[13]  Y. Kaneda,et al.  Gene therapy inhibiting neointimal vascular lesion: in vivo transfer of endothelial cell nitric oxide synthase gene. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[14]  K. Hirata,et al.  Inhibition of endothelial nitric oxide synthase activity by protein kinase C. , 1995, Hypertension.

[15]  G. Rubanyi,et al.  Gender difference in bioassayable endothelium-derived nitric oxide from isolated rat aortae. , 1994, The American journal of physiology.

[16]  D. Harrison,et al.  Organization of the bovine gene encoding the endothelial nitric oxide synthase. , 1994, Biochimica et biophysica acta.

[17]  I. Charles,et al.  Induction of calcium-dependent nitric oxide synthases by sex hormones. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[18]  S. Milstien,et al.  Regulation of nitric oxide synthesis by proinflammatory cytokines in human umbilical vein endothelial cells. Elevations in tetrahydrobiopterin levels enhance endothelial nitric oxide synthase specific activity. , 1994, The Journal of clinical investigation.

[19]  W. Sessa.  The nitric oxide synthase family of proteins. , 1994, Journal of vascular research.

[20]  J. Catravas,et al.  Smooth muscle cell responsiveness to nitrovasodilators in hypertensive and normotensive rats. , 1994, Hypertension.

[21]  M. Kuchan,et al.  Role of calcium and calmodulin in flow-induced nitric oxide production in endothelial cells. , 1994, The American journal of physiology.

[22]  B. Tönshoff,et al.  Direct demonstration of insulin-like growth factor-I-induced nitric oxide production by endothelial cells. , 1994, Kidney international.

[23]  T. Michel,et al.  Phosphorylation and subcellular translocation of endothelial nitric oxide synthase. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[24]  L. Ignarro,et al.  Basal release of nitric oxide from aortic rings is greater in female rabbits than in male rabbits: implications for atherosclerosis. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[25]  B. Vanderhyden,et al.  A new, nongenomic estrogen action: the rapid release of intracellular calcium. , 1992, Endocrinology.

[26]  M J Peach,et al.  Molecular cloning and expression of a cDNA encoding endothelial cell nitric oxide synthase. , 1992, The Journal of biological chemistry.

[27]  C. Nathan,et al.  Calmodulin is a subunit of nitric oxide synthase from macrophages , 1992, The Journal of experimental medicine.

[28]  D. Herrington,et al.  Short-term administration of estrogen and vascular responses of atherosclerotic coronary arteries. , 1992, Journal of the American College of Cardiology.

[29]  C. Koumenis,et al.  Alteration of the phase and period of a circadian oscillator by a reversible transcription inhibitor. , 1991, Science.

[30]  P. Kubes,et al.  Nitric oxide: an endogenous modulator of leukocyte adhesion. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[31]  E. Barrett-Connor,et al.  Estrogen and coronary heart disease in women , 1991, JAMA.

[32]  R. Palmer,et al.  Nitric oxide and prostacyclin. Divergence of inhibitory effects on monocyte chemotaxis and adhesion to endothelium in vitro. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.

[33]  F. Murad,et al.  Calmodulin-dependent endothelium-derived relaxing factor/nitric oxide synthase activity is present in the particulate and cytosolic fractions of bovine aortic endothelial cells. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[34]  S. Moncada,et al.  An L-arginine/nitric oxide pathway present in human platelets regulates aggregation. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[35]  A. Hassid,et al.  Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. , 1989, The Journal of clinical investigation.

[36]  L. Ignarro,et al.  Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[37]  S. Moncada,et al.  ENDOGENOUS NITRIC OXIDE INHIBITS HUMAN PLATELET ADHESION TO VASCULAR ENDOTHELIUM , 1987, The Lancet.

[38]  S. Moncada,et al.  Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor , 1987, Nature.

[39]  E. Barrett-Connor,et al.  Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study. , 1987, Circulation.

[40]  W. Kearns,et al.  Potassium infusion attenuates avoidance-saline hypertension in dogs. , 1983, Hypertension.

[41]  D. Koritnik,et al.  Estrogen pretreatment directly potentiates endothelium-dependent vasorelaxation of porcine coronary arteries. , 1995, The American journal of physiology.

[42]  Von der Leyen.  Gene therapy inhibiting neointimal vascular lesion , 1995 .

[43]  S. Reis,et al.  Ethinyl estradiol acutely attenuates abnormal coronary vasomotor responses to acetylcholine in postmenopausal women. , 1994, Circulation.

[44]  M. Gimbrone.  Culture of vascular endothelium. , 1976, Progress in hemostasis and thrombosis.